Holen Sie sich die Stockscreener-App
6.32
2.10%
0.13
Handel nachbörslich:
6.32
Schlusskurs vom Vortag:
$6.19
Offen:
$6.04
24-Stunden-Volumen:
1.36M
Relative Volume:
2.05
Marktkapitalisierung:
$814.08M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-158.00
EPS:
-0.04
Netto-Cashflow:
$454.00K
1W Leistung:
+1.77%
1M Leistung:
+3.10%
6M Leistung:
+15.96%
1J Leistung:
-32.26%
1-Tages-Spanne:
$6.04
$6.39
1-Wochen-Bereich:
$6.04
$6.78
52-Wochen-Spanne:
$4.66
$9.87
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
6.32 | 814.08M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
(CTKB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 4.8%Should You Buy? - MarketBeat
The Manufacturers Life Insurance Company Lowers Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Is Cytek Biosciences (NASDAQ:CTKB) Weighed On By Its Debt Load? - Simply Wall St
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Wellington Management Group LLP - MarketBeat
Verition Fund Management LLC Raises Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Stock Price Down 5.4%What's Next? - MarketBeat
Fmr LLC Purchases 30,386 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Charles Schwab Investment Management Inc. Has $5.71 Million Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Jacobs Levy Equity Management Inc. Invests $1.01 Million in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Acquired by Thrivent Financial for Lutherans - Defense World
Advancements in Mass Cytometry (CyTOF) to Accelerate Growth of the Flow Cytometry Market for the Coming Decade, Says Future Market Insights, Inc. - GlobeNewswire Inc.
Cytek Biosciences stock target cut, overweight on revised estimates - Investing.com
Cytek Biosciences stock target cut, overweight on revised estimates By Investing.com - Investing.com Canada
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by GSA Capital Partners LLP - Defense World
Principal Financial Group Inc. Purchases 23,028 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Brown Capital Management LLC Trims Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Cytek Biosciences to Present at Piper Sandler Healthcare Conference 2024 | CTKB Stock News - StockTitan
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program - GlobeNewswire
Cytek Biosciences Crowned 2024 BioTech Company of the Year, Leading in Flow Cytometry | CTKB Stock News - StockTitan
Cytek Biosciences (NASDAQ:CTKB) Shares Gap DownShould You Sell? - MarketBeat
Learn to Evaluate (CTKB) using the Charts - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Significant Decrease in Short Interest - MarketBeat
Brown Capital Management LLC Adjusts Stake in Cytek Biosciences Inc - GuruFocus.com
Piper Sandler Forecasts Strong Price Appreciation for Cytek Biosciences (NASDAQ:CTKB) Stock - Defense World
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter - The Manila Times
CTKBCytek Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Cytek Biosciences Inc. (CTKB) Quarterly 10-Q Report - Quartzy
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Call Transcript - Insider Monkey
Investors Still Aren't Entirely Convinced By Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Despite 46% Price Jump - Simply Wall St
Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Shares Up 26.7% After Strong Earnings - Defense World
Earnings call: Cytek Biosciences reports steady growth in Q3 2024 By Investing.com - Investing.com South Africa
Earnings call: Cytek Biosciences reports steady growth in Q3 2024 - Investing.com India
Cytek Biosciences (NASDAQ:CTKB) Shares Up 26.7% After Earnings Beat - MarketBeat
U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ... By GuruFocus - Investing.com Canada
Cytek Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Cytek Biosciences’ Q3 2024 Financial Highlights - TipRanks
Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat Estimates - MSN
Cytek Biosciences earnings matched, revenue topped estimates - Investing.com
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings: Revenue Hits $51. - GuruFocus.com
Cytek Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Preview: Cytek Biosciences's Earnings - Benzinga
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2024 Earnings - Yahoo Finance
November 2024's Top US Penny Stocks With Growth Potential - Simply Wall St
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Biosciences (CTKB) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 - GlobeNewswire
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Apr 09 '24 |
Sale |
7.00 |
1,900 |
13,304 |
6,008,502 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 18 '24 |
Sale |
6.77 |
20,000 |
135,400 |
6,030,402 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 19 '24 |
Sale |
6.71 |
20,000 |
134,200 |
6,010,402 |
| Jeanmonod Patrik | Chief Financial Officer |
Dec 26 '23 |
Sale |
9.50 |
3,000 |
28,500 |
93,400 |
1.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):